LEVODOPA

LEVODOPA was reported 47271 times

LEVODOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALIVA DISCOLOURATION 97 0.2904
1 DOPAMINE DYSREGULATION SYNDROME 82 0.1839
2 POSTURAL REFLEX IMPAIRMENT 8 0.1538
3 PHLEBITIS INFECTIVE 9 0.1250
4 PARAPHILIA 15 0.1154
5 PRODUCT RESIDUE PRESENT 571 0.1058
6 NASAL MUCOSAL DISCOLOURATION 17 0.1056
7 PATIENT DISSATISFACTION WITH DEVICE 25 0.0992
8 CAMPTOCORMIA 23 0.0958
9 THERAPEUTIC PRODUCT EFFECT VARIABLE 332 0.0855
10 DEEP BRAIN STIMULATION 45 0.0745
11 NASAL DISCHARGE DISCOLOURATION 88 0.0638
12 JEALOUS DELUSION 18 0.0636
13 ON AND OFF PHENOMENON 351 0.0632
14 PARKINSONISM HYPERPYREXIA SYNDROME 11 0.0615
15 MUCOSAL DISCOLOURATION 38 0.0592
16 FREEZING PHENOMENON 215 0.0580
17 DEVICE COLOUR ISSUE 23 0.0569
18 EXPULSION OF MEDICATION 30 0.0567
19 VASCULAR ENCEPHALOPATHY 16 0.0563
20 STOMA SITE IRRITATION 29 0.0533
21 PLEUROTHOTONUS 46 0.0509
22 PROGRESSIVE SUPRANUCLEAR PALSY 10 0.0498
23 IMPULSE-CONTROL DISORDER 99 0.0481
24 SPEECH SOUND DISORDER 8 0.0465
25 FIBROMA 40 0.0435
26 DROPPED HEAD SYNDROME 17 0.0430
27 REDUCED FACIAL EXPRESSION 43 0.0424
28 SUPINE HYPERTENSION 8 0.0423
29 DIASTOLIC HYPOTENSION 7 0.0414
30 GLOSSOPTOSIS 9 0.0411
31 STOMA SITE ODOUR 9 0.0402
32 STOMA SITE REACTION 27 0.0394
33 STOMA SITE ERYTHEMA 68 0.0364
34 STOMA SITE DISCHARGE 89 0.0325
35 AKINESIA 66 0.0318
36 CATHETER SITE INDURATION 6 0.0311
37 STOMA SITE DISCOMFORT 7 0.0308
38 INTENTIONAL UNDERDOSE 203 0.0278
39 DEVICE USE ISSUE 463 0.0264
40 PRODUCT PACKAGING DIFFICULT TO OPEN 69 0.0264
41 STOMA SITE EXTRAVASATION 10 0.0259
42 HYPERSEXUALITY 47 0.0257
43 BRADYKINESIA 151 0.0256
44 HYPERKINESIA 54 0.0254
45 STOMA SITE PAIN 37 0.0252
46 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 10 0.0249
47 SPUTUM DISCOLOURED 236 0.0249
48 PATHOLOGICAL GAMBLING 41 0.0247
49 PARKINSONIAN GAIT 15 0.0240
50 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 6 0.0237
51 STOMA SITE INFLAMMATION 17 0.0228
52 MULTIPLE SYSTEM ATROPHY 8 0.0227
53 PRODUCT CLEANING INADEQUATE 59 0.0221
54 CHOKING SENSATION 117 0.0212
55 DEVICE OCCLUSION 289 0.0205
56 RESTING TREMOR 13 0.0201
57 MASKED FACIES 8 0.0197
58 SOFT TISSUE MASS 9 0.0195
59 DYSKINESIA 785 0.0193
60 STEREOTYPY 18 0.0191
61 STOMA SITE HYPERGRANULATION 12 0.0190
62 EUTHANASIA 6 0.0189
63 MESENTERIC ARTERY THROMBOSIS 7 0.0182
64 RESPIRATORY TRACT IRRITATION 19 0.0182
65 COMPULSIONS 12 0.0180
66 THERAPEUTIC PRODUCT EFFECT DELAYED 82 0.0180
67 MUSCLE RIGIDITY 214 0.0179
68 ORTHOSTATIC INTOLERANCE 12 0.0167
69 PARKINSON'S DISEASE 41 0.0161
70 COMPULSIVE SHOPPING 33 0.0160
71 SUDDEN ONSET OF SLEEP 22 0.0159
72 GAMBLING 18 0.0154
73 OROMANDIBULAR DYSTONIA 11 0.0151
74 TORTICOLLIS 32 0.0151
75 MARITAL PROBLEM 8 0.0148
76 ECZEMA EYELIDS 8 0.0143
77 MEDICAL DEVICE SITE PAIN 8 0.0142
78 STOMA SITE INFECTION 18 0.0138
79 ENTERAL NUTRITION 8 0.0138
80 HYPERBILIRUBINAEMIA NEONATAL 8 0.0137
81 BINGE EATING 14 0.0130
82 CHOKING 253 0.0130
83 LIVING IN RESIDENTIAL INSTITUTION 24 0.0128
84 DEMENTIA WITH LEWY BODIES 14 0.0126
85 STOMA SITE HAEMORRHAGE 19 0.0123
86 POSTURE ABNORMAL 40 0.0123
87 DERMATILLOMANIA 7 0.0117
88 DEVICE LOOSENING 10 0.0116
89 HALLUCINATION, VISUAL 244 0.0115
90 INFUSION SITE CELLULITIS 6 0.0114
91 INFUSION SITE INFLAMMATION 8 0.0113
92 SALIVA ALTERED 10 0.0111
93 ILLUSION 18 0.0109
94 YAWNING 29 0.0109
95 PRODUCT AFTER TASTE 10 0.0105
96 COGWHEEL RIGIDITY 11 0.0105
97 INFUSION SITE NODULE 10 0.0104
98 DEVICE INEFFECTIVE 11 0.0103
99 DEVICE MAINTENANCE ISSUE 6 0.0102
100 THERAPEUTIC PRODUCT CROSS-REACTIVITY 9 0.0101
101 COMPULSIVE SEXUAL BEHAVIOUR 8 0.0099
102 RECALL PHENOMENON 8 0.0096
103 NEUROLEPTIC MALIGNANT SYNDROME 112 0.0094
104 PRODUCT COMMUNICATION ISSUE 83 0.0094
105 PERSECUTORY DELUSION 23 0.0092
106 HALLUCINATION 674 0.0089
107 HEAT ILLNESS 6 0.0089
108 PARKINSONISM 85 0.0087
109 CHOREA 15 0.0087
110 KETONURIA 7 0.0086
111 TENSION 52 0.0085
112 DELUSION 132 0.0085
113 ACIDOSIS HYPERCHLORAEMIC 5 0.0084
114 COUGH 2350 0.0084
115 DYSTONIA 160 0.0082
116 DRUG EFFECT LESS THAN EXPECTED 120 0.0081
117 URGE INCONTINENCE 7 0.0080
118 DEVICE ISSUE 721 0.0080
119 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
120 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 8 0.0079
121 DEVICE DIFFICULT TO USE 523 0.0079
122 STOMA COMPLICATION 8 0.0079
123 GRIMACING 6 0.0077
124 INFUSION SITE INDURATION 11 0.0074
125 FEAR OF FALLING 6 0.0074
126 SUBILEUS 15 0.0072
127 DRY THROAT 73 0.0072
128 GAMBLING DISORDER 19 0.0070
129 ALANINE AMINOTRANSFERASE DECREASED 5 0.0069
130 LIBIDO INCREASED 14 0.0069
131 INCORRECT DOSE ADMINISTERED BY DEVICE 175 0.0067
132 NUCHAL RIGIDITY 6 0.0066
133 DEVICE CONNECTION ISSUE 14 0.0066
134 MYOCLONUS 79 0.0066
135 HEAT STROKE 10 0.0066
136 INFUSION SITE WARMTH 8 0.0065
137 PRODUCT PHYSICAL ISSUE 131 0.0065
138 STREPTOCOCCAL BACTERAEMIA 7 0.0064
139 HYPOKINESIA 92 0.0063
140 PRESCRIBED UNDERDOSE 126 0.0063
141 INTERMITTENT CLAUDICATION 10 0.0063
142 ANTICHOLINERGIC SYNDROME 10 0.0063
143 FINE MOTOR SKILL DYSFUNCTION 18 0.0062
144 DRUG EFFECT VARIABLE 7 0.0062
145 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 286 0.0061
146 OROPHARYNGEAL DISCOMFORT 55 0.0061
147 INFUSION SITE INFECTION 14 0.0060
148 SALIVARY HYPERSECRETION 60 0.0060
149 HYPERCAPNIA 18 0.0060
150 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17 0.0058
151 PATIENT DISSATISFACTION WITH TREATMENT 11 0.0057
152 REHABILITATION THERAPY 22 0.0057
153 LIP DISCOLOURATION 7 0.0055
154 DEVICE ALARM ISSUE 10 0.0055
155 NONSPECIFIC REACTION 30 0.0055
156 GALLBLADDER CANCER 8 0.0054
157 ERYSIPELAS 27 0.0054
158 DROOLING 37 0.0054
159 OBSESSIVE-COMPULSIVE DISORDER 42 0.0052
160 CYSTITIS NONINFECTIVE 7 0.0052
161 DEVICE KINK 19 0.0052
162 BLADDER CATHETERISATION 5 0.0052
163 GASTROSTOMY 8 0.0052
164 ORTHOSTATIC HYPOTENSION 89 0.0051
165 WHEELCHAIR USER 22 0.0049
166 DEMENTIA 138 0.0049
167 RESPIRATORY DISORDER NEONATAL 8 0.0049
168 ACUTE PSYCHOSIS 12 0.0048
169 SUFFOCATION FEELING 12 0.0048
170 MUTISM 7 0.0048
171 IMPULSIVE BEHAVIOUR 18 0.0048
172 THROAT IRRITATION 206 0.0046
173 DYSCHEZIA 14 0.0046
174 SPEECH DISORDER 240 0.0046
175 INHIBITORY DRUG INTERACTION 7 0.0044
176 CORNEAL OPACITY 6 0.0044
177 RETCHING 93 0.0044
178 HEAD TITUBATION 6 0.0044
179 INFUSION SITE REACTION 13 0.0043
180 BEZOAR 6 0.0043
181 HYPERREFLEXIA 15 0.0043
182 URINARY TRACT OBSTRUCTION 10 0.0042
183 CATHETER SITE ERYTHEMA 9 0.0042
184 BRADYPHRENIA 27 0.0041
185 SPINAL STENOSIS 17 0.0041
186 INITIAL INSOMNIA 42 0.0041
187 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 70 0.0041
188 APRAXIA 6 0.0040
189 NOCTURIA 49 0.0040
190 INFREQUENT BOWEL MOVEMENTS 10 0.0040
191 FAECALOMA 22 0.0040
192 CEREBRAL ATROPHY 16 0.0040
193 FOOD INTERACTION 7 0.0040
194 TERMINAL INSOMNIA 7 0.0040
195 FEMORAL NECK FRACTURE 20 0.0039
196 OBSESSIVE THOUGHTS 7 0.0039
197 BEHAVIOUR DISORDER 21 0.0039
198 CATHETER SITE PAIN 10 0.0039
199 DELIRIUM 133 0.0038
200 MOTOR DYSFUNCTION 39 0.0038
201 HYPOMANIA 14 0.0038
202 OCULOGYRIC CRISIS 8 0.0037
203 INFUSION SITE BRUISING 8 0.0037
204 PRODUCT COLOUR ISSUE 19 0.0037
205 SHOULDER FRACTURE 6 0.0037
206 DYSGRAPHIA 24 0.0036
207 LISTLESS 12 0.0036
208 RESTLESSNESS 133 0.0036
209 DEVICE DELIVERY SYSTEM ISSUE 99 0.0036
210 PARANOIA 61 0.0035
211 HYPERTHERMIA 27 0.0035
212 GAZE PALSY 6 0.0035
213 MOVEMENT DISORDER 112 0.0035
214 THROAT CLEARING 13 0.0035
215 PERSONALITY DISORDER 9 0.0034
216 CATATONIA 18 0.0034
217 NEGATIVE THOUGHTS 10 0.0034
218 PSYCHOTIC SYMPTOM 7 0.0034
219 IMPAIRED SELF-CARE 7 0.0034
220 COLITIS MICROSCOPIC 16 0.0034
221 BODY TEMPERATURE FLUCTUATION 7 0.0034
222 COGNITIVE DISORDER 156 0.0033
223 TREMOR 554 0.0033
224 HALLUCINATIONS, MIXED 14 0.0033
225 RESTLESS LEGS SYNDROME 59 0.0032
226 ABNORMAL DREAMS 89 0.0032
227 DIZZINESS POSTURAL 31 0.0032
228 INTERVERTEBRAL DISCITIS 6 0.0032
229 FOREIGN BODY IN THROAT 10 0.0032
230 MICTURITION DISORDER 11 0.0032
231 DEVICE DEFECTIVE 55 0.0032
232 ABNORMAL FAECES 26 0.0032
233 ILEUS 39 0.0031
234 CORNEAL OEDEMA 7 0.0031
235 FACIAL PARESIS 11 0.0031
236 PNEUMONIA ASPIRATION 76 0.0030
237 ABDOMINAL TENDERNESS 15 0.0030
238 ALCOHOL ABUSE 8 0.0030
239 PELVIC FRACTURE 23 0.0030
240 THERAPEUTIC PRODUCT EFFECT DECREASED 132 0.0029
241 PSYCHOTIC DISORDER 86 0.0029
242 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
243 CERVICAL VERTEBRAL FRACTURE 10 0.0029
244 FORMICATION 20 0.0029
245 PHYSICAL ASSAULT 6 0.0029
246 THERAPEUTIC RESPONSE DELAYED 8 0.0029
247 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 203 0.0029
248 EYE CONTUSION 6 0.0028
249 GASTROINTESTINAL SOUNDS ABNORMAL 14 0.0028
250 APATHY 41 0.0028
251 RESPIRATORY ACIDOSIS 11 0.0028
252 BLOOD PRESSURE FLUCTUATION 67 0.0028
253 ILL-DEFINED DISORDER 168 0.0028
254 IMMOBILE 12 0.0027
255 MOBILITY DECREASED 196 0.0027
256 TERMINAL STATE 18 0.0027
257 CONDITION AGGRAVATED 818 0.0027
258 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
259 POTENTIATING DRUG INTERACTION 9 0.0027
260 ABNORMAL BEHAVIOUR 106 0.0027
261 MIDDLE INSOMNIA 49 0.0026
262 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
263 COMMUNICATION DISORDER 10 0.0026
264 GAIT INABILITY 87 0.0026
265 SEROTONIN SYNDROME 50 0.0026
266 POOR QUALITY SLEEP 56 0.0026
267 BLOOD SODIUM INCREASED 7 0.0026
268 BRADYPNOEA 7 0.0026
269 HYPOPNOEA 9 0.0026
270 THROMBOPHLEBITIS 9 0.0026
271 CLONUS 7 0.0026
272 AMMONIA INCREASED 13 0.0025
273 EUPHORIC MOOD 26 0.0025
274 VOLVULUS 6 0.0025
275 DEVICE PLACEMENT ISSUE 9 0.0025
276 BALANCE DISORDER 217 0.0025
277 GENERAL PHYSICAL CONDITION ABNORMAL 17 0.0025
278 ORAL INTAKE REDUCED 6 0.0025
279 VITAMIN B12 DEFICIENCY 10 0.0025
280 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
281 MUSCULOSKELETAL STIFFNESS 211 0.0024
282 FLUID INTAKE REDUCED 12 0.0024
283 FAECES HARD 9 0.0023
284 HIP FRACTURE 74 0.0023
285 MEDICAL DEVICE DISCOMFORT 7 0.0023
286 NASAL DISCOMFORT 18 0.0023
287 HALLUCINATION, AUDITORY 36 0.0023
288 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
289 THERAPY CESSATION 113 0.0022
290 FALL 732 0.0022
291 POLYURIA 18 0.0022
292 BRAIN OPERATION 5 0.0022
293 GAIT DISTURBANCE 417 0.0022
294 DISORIENTATION 86 0.0022
295 ORAL DISCOMFORT 30 0.0022
296 FACE INJURY 8 0.0021
297 SKIN MASS 14 0.0021
298 HEART VALVE INCOMPETENCE 6 0.0021
299 BOWEL MOVEMENT IRREGULARITY 16 0.0021
300 SOMNOLENCE 418 0.0021
301 EXPIRED PRODUCT ADMINISTERED 69 0.0021
302 HYPOPHAGIA 53 0.0021
303 DYSSTASIA 60 0.0021
304 WOUND SECRETION 8 0.0020
305 TOOTH DISCOLOURATION 6 0.0020
306 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
307 NIGHTMARE 70 0.0020
308 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97 0.0020
309 CATHETER SITE HAEMORRHAGE 5 0.0020
310 SLEEP DISORDER 141 0.0020
311 DEPRESSIVE SYMPTOM 7 0.0020
312 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
313 WALKING AID USER 13 0.0020
314 PRODUCT USE COMPLAINT 31 0.0020
315 BLOOD PRESSURE DECREASED 130 0.0020
316 DRY MOUTH 158 0.0019
317 SCOLIOSIS 12 0.0019
318 CONFUSIONAL STATE 312 0.0019
319 PRODUCT ADMINISTRATION ERROR 39 0.0019
320 WRONG PRODUCT ADMINISTERED 13 0.0019
321 HYPERTONIA 11 0.0019
322 APHASIA 58 0.0019
323 SECRETION DISCHARGE 24 0.0019
324 HYPERVENTILATION 11 0.0019
325 PRODUCT PACKAGING ISSUE 18 0.0019
326 WOUND HAEMORRHAGE 7 0.0019
327 AGITATION 139 0.0019
328 HYPERPYREXIA 8 0.0019
329 BILE DUCT STONE 6 0.0019
330 MANIA 31 0.0019
331 PRODUCT DISPENSING ISSUE 8 0.0019
332 PEMPHIGOID 14 0.0019
333 INCOHERENT 12 0.0019
334 HYPOVENTILATION 6 0.0018
335 CLAVICLE FRACTURE 7 0.0018
336 DYSPHEMIA 8 0.0018
337 INFLAMMATORY MARKER INCREASED 9 0.0018
338 HYPERSOMNIA 52 0.0018
339 BLADDER DISORDER 18 0.0018
340 PANIC DISORDER 7 0.0018
341 GENERAL PHYSICAL HEALTH DETERIORATION 208 0.0018
342 ANXIETY DISORDER 6 0.0018
343 DYSPHORIA 9 0.0018
344 AGGRESSION 89 0.0018
345 ADVERSE EVENT 163 0.0018
346 POLYNEUROPATHY 21 0.0018
347 INFUSION SITE SWELLING 11 0.0017
348 DEVICE DISLOCATION 76 0.0017
349 TRISMUS 9 0.0017
350 SCREAMING 11 0.0017
351 DYSARTHRIA 65 0.0017
352 HOSPICE CARE 17 0.0017
353 PERIPHERAL VENOUS DISEASE 7 0.0017
354 RIB FRACTURE 35 0.0017
355 UNEVALUABLE EVENT 128 0.0017
356 TACHYPNOEA 23 0.0017
357 EATING DISORDER 36 0.0017
358 SLUGGISHNESS 17 0.0017
359 DYSPHAGIA 158 0.0017
360 INFUSION SITE ERYTHEMA 14 0.0017
361 AORTIC VALVE INCOMPETENCE 7 0.0016
362 PRODUCT PRESCRIBING ERROR 39 0.0016
363 TRICUSPID VALVE INCOMPETENCE 13 0.0016
364 DYSPHONIA 95 0.0016
365 BREATH SOUNDS ABNORMAL 8 0.0016
366 SUDDEN DEATH 17 0.0016
367 HYPERNATRAEMIA 8 0.0016
368 CHOLECYSTITIS ACUTE 9 0.0016
369 CATHETER SITE INFECTION 6 0.0016
370 HYPOTHERMIA 16 0.0016
371 TROPONIN INCREASED 12 0.0016
372 DEVICE PHYSICAL PROPERTY ISSUE 12 0.0016
373 SEDATION 41 0.0016
374 SKIN LACERATION 17 0.0016
375 OESOPHAGEAL ULCER 6 0.0016
376 URINARY TRACT DISORDER 7 0.0016
377 CONCUSSION 12 0.0015
378 PRODUCTIVE COUGH 73 0.0015
379 PROSTATOMEGALY 6 0.0015
380 PANIC REACTION 11 0.0015
381 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
382 TONGUE DISORDER 11 0.0015
383 POLYDIPSIA 6 0.0015
384 JOINT DISLOCATION 16 0.0015
385 CARDIAC PACEMAKER INSERTION 9 0.0015
386 MEMORY IMPAIRMENT 207 0.0015
387 HYPERPHAGIA 6 0.0015
388 MICTURITION URGENCY 17 0.0015
389 CEREBRAL HAEMATOMA 5 0.0015
390 HIP SURGERY 8 0.0015
391 PRODUCT TASTE ABNORMAL 20 0.0015
392 ASPHYXIA 12 0.0015
393 PARALYSIS 21 0.0015
394 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
395 APHAGIA 7 0.0015
396 RESPIRATION ABNORMAL 10 0.0014
397 SOCIAL PROBLEM 6 0.0014
398 THERAPEUTIC RESPONSE UNEXPECTED 65 0.0014
399 ANAL INCONTINENCE 13 0.0014
400 FOOT DEFORMITY 16 0.0014
401 SUICIDAL BEHAVIOUR 6 0.0014
402 URINARY RETENTION 48 0.0014
403 MALNUTRITION 16 0.0014
404 TREATMENT NONCOMPLIANCE 78 0.0014
405 INCONTINENCE 15 0.0014
406 DEPRESSED MOOD 75 0.0014
407 UROSEPSIS 13 0.0014
408 CARDIAC FAILURE CHRONIC 6 0.0014
409 PERONEAL NERVE PALSY 8 0.0014
410 ACUTE RESPIRATORY FAILURE 27 0.0014
411 AFFECTIVE DISORDER 11 0.0014
412 SHOCK 32 0.0014
413 HEAD INJURY 44 0.0014
414 BONE LESION 5 0.0014
415 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 248 0.0014
416 BEDRIDDEN 18 0.0014
417 MAJOR DEPRESSION 10 0.0014
418 SPINAL OSTEOARTHRITIS 12 0.0014
419 COORDINATION ABNORMAL 19 0.0014
420 CORONAVIRUS INFECTION 9 0.0014
421 CACHEXIA 7 0.0014
422 MUSCLE DISORDER 11 0.0014
423 PSYCHIATRIC SYMPTOM 10 0.0014
424 DISTURBANCE IN ATTENTION 73 0.0014
425 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
426 THINKING ABNORMAL 25 0.0013
427 SENSITIVITY TO WEATHER CHANGE 7 0.0013
428 COMA 63 0.0013
429 SYNCOPE 132 0.0013
430 DERMATITIS CONTACT 15 0.0013
431 INGUINAL HERNIA 8 0.0013
432 RHINORRHOEA 85 0.0013
433 DEPRESSED LEVEL OF CONSCIOUSNESS 52 0.0013
434 EYE MOVEMENT DISORDER 9 0.0013
435 DISCOMFORT 80 0.0013
436 DISEASE COMPLICATION 6 0.0013
437 SENSORY DISTURBANCE 21 0.0013
438 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
439 BRUXISM 7 0.0013
440 HAEMOLYSIS 10 0.0013
441 PANIC ATTACK 47 0.0013
442 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 261 0.0013
443 FEELING OF DESPAIR 6 0.0013
444 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
445 CHROMATURIA 29 0.0013
446 TASTE DISORDER 26 0.0013
447 NASAL DRYNESS 8 0.0013
448 FEAR 34 0.0013
449 HUMERUS FRACTURE 6 0.0012
450 FRUSTRATION TOLERANCE DECREASED 10 0.0012
451 URINARY TRACT INFECTION 211 0.0012
452 MITRAL VALVE INCOMPETENCE 14 0.0012
453 INCORRECT DOSAGE ADMINISTERED 6 0.0012
454 DRUG INTERACTION 194 0.0012
455 EMBEDDED DEVICE 12 0.0012
456 MENTAL IMPAIRMENT 29 0.0012
457 ASPIRATION 13 0.0012
458 ENERGY INCREASED 7 0.0012
459 PERSONALITY CHANGE 11 0.0012
460 CIRCULATORY COLLAPSE 20 0.0012
461 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
462 WEIGHT FLUCTUATION 12 0.0011
463 DEFAECATION URGENCY 8 0.0011
464 FOOD CRAVING 6 0.0011
465 MOOD ALTERED 31 0.0011
466 ADVERSE DRUG REACTION 102 0.0011
467 LIMB DISCOMFORT 35 0.0011
468 UNRESPONSIVE TO STIMULI 29 0.0011
469 CONSTIPATION 245 0.0011
470 DRUG INEFFECTIVE 1474 0.0011
471 MUSCULAR WEAKNESS 126 0.0011
472 DECUBITUS ULCER 9 0.0011
473 FEELING JITTERY 21 0.0011
474 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
475 FEELING ABNORMAL 261 0.0011
476 SPINAL COMPRESSION FRACTURE 9 0.0011
477 WRIST FRACTURE 13 0.0011
478 LUNG DISORDER 53 0.0011
479 HEART RATE ABNORMAL 6 0.0011
480 ATRIAL SEPTAL DEFECT 9 0.0011
481 HEAD DISCOMFORT 19 0.0011
482 WITHDRAWAL SYNDROME 45 0.0011
483 SENSATION OF FOREIGN BODY 9 0.0011
484 PAROSMIA 8 0.0011
485 INSOMNIA 282 0.0011
486 SOPOR 14 0.0011
487 POLLAKIURIA 44 0.0011
488 MUSCLE TIGHTNESS 17 0.0010
489 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
490 ANURIA 9 0.0010
491 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
492 PRESCRIBED OVERDOSE 20 0.0010
493 SNEEZING 23 0.0010
494 GRIP STRENGTH DECREASED 9 0.0010
495 COLD SWEAT 18 0.0010
496 PERIPHERAL COLDNESS 14 0.0010
497 KNEE OPERATION 10 0.0010
498 MYDRIASIS 13 0.0010
499 DEVICE BREAKAGE 41 0.0010
500 PRODUCT PRESCRIBING ISSUE 22 0.0010
501 UPPER LIMB FRACTURE 20 0.0010
502 APHONIA 14 0.0010
503 HYPERHIDROSIS 129 0.0010
504 BRADYCARDIA 53 0.0010
505 MIOSIS 8 0.0010
506 INCORRECT DOSE ADMINISTERED 227 0.0010
507 ANXIETY 283 0.0010
508 SENSORY LOSS 8 0.0010
509 MUSCLE SPASMS 182 0.0010
510 HAND FRACTURE 7 0.0010
511 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
512 HYPOTENSION 198 0.0010
513 HERNIA 19 0.0010
514 THERAPY NON-RESPONDER 44 0.0010
515 ENCEPHALOPATHY 24 0.0010
516 NEUTROPHIL COUNT INCREASED 10 0.0010
517 NERVE COMPRESSION 9 0.0010
518 IMPAIRED QUALITY OF LIFE 14 0.0010
519 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
520 IMPAIRED DRIVING ABILITY 11 0.0010
521 EXTRAPYRAMIDAL DISORDER 24 0.0010
522 BLOOD SODIUM DECREASED 18 0.0010
523 FRACTURE 18 0.0009
524 UNINTENTIONAL MEDICAL DEVICE REMOVAL 11 0.0009
525 PHOTOPSIA 6 0.0009
526 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
527 ARTHROPOD BITE 7 0.0009
528 SLEEP APNOEA SYNDROME 18 0.0009
529 FEELING DRUNK 7 0.0009
530 DIZZINESS 469 0.0009
531 GLAUCOMA 18 0.0009
532 FEELING COLD 26 0.0009
533 DEHYDRATION 124 0.0009
534 LACRIMATION INCREASED 28 0.0009
535 HAEMODYNAMIC INSTABILITY 7 0.0009
536 URINARY INCONTINENCE 27 0.0009
537 RHABDOMYOLYSIS 38 0.0009
538 LIGAMENT SPRAIN 9 0.0009
539 THERAPY INTERRUPTED 65 0.0009
540 TOOTH FRACTURE 10 0.0009
541 APPETITE DISORDER 6 0.0009
542 BRAIN FOG 14 0.0009
543 ANGIOPATHY 5 0.0009
544 PRODUCT LABEL ISSUE 6 0.0009
545 RENAL CYST 7 0.0009
546 LIP DRY 8 0.0009
547 NERVOUSNESS 46 0.0009
548 LOSS OF CONSCIOUSNESS 112 0.0009
549 FEMUR FRACTURE 27 0.0009
550 ECONOMIC PROBLEM 13 0.0009
551 TOOTH DISORDER 19 0.0009
552 HEART RATE DECREASED 30 0.0009
553 HYPONATRAEMIA 48 0.0009
554 DEATH 733 0.0008
555 DUODENAL ULCER 6 0.0008
556 SPINAL DISORDER 8 0.0008
557 EMOTIONAL DISORDER 26 0.0008
558 ATAXIA 10 0.0008
559 DRUG INTOLERANCE 81 0.0008
560 MACULAR DEGENERATION 10 0.0008
561 MENTAL STATUS CHANGES 23 0.0008
562 SINUS BRADYCARDIA 8 0.0008
563 BACK INJURY 9 0.0008
564 PRESYNCOPE 20 0.0008
565 VITAMIN D DEFICIENCY 8 0.0008
566 RESPIRATORY TRACT CONGESTION 13 0.0008
567 EPILEPSY 25 0.0008
568 DERMATITIS 17 0.0008
569 NERVE INJURY 9 0.0008
570 MUSCLE STRAIN 7 0.0008
571 PYELONEPHRITIS 7 0.0008
572 HAEMORRHAGE INTRACRANIAL 12 0.0008
573 NEUROTOXICITY 14 0.0008
574 SPINAL FRACTURE 16 0.0008
575 BLEPHAROSPASM 5 0.0008
576 FEEDING DISORDER 16 0.0008
577 IRRITABILITY 47 0.0008
578 MENTAL DISORDER 34 0.0008
579 LOWER LIMB FRACTURE 15 0.0008
580 DEVICE RELATED INFECTION 12 0.0008
581 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
582 THROAT TIGHTNESS 21 0.0008
583 WHEEZING 46 0.0008
584 TEMPERATURE INTOLERANCE 8 0.0008
585 SUBDURAL HAEMATOMA 11 0.0008
586 UNDERDOSE 56 0.0008
587 OROPHARYNGEAL PAIN 71 0.0008
588 ANOSMIA 11 0.0008
589 PULMONARY CONGESTION 10 0.0008
590 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
591 WEIGHT DECREASED 211 0.0008
592 DYSGEUSIA 56 0.0008
593 WOUND 21 0.0008
594 DISEASE PROGRESSION 88 0.0007
595 BACK DISORDER 12 0.0007
596 CARDIOMEGALY 9 0.0007
597 DIPLOPIA 19 0.0007
598 SPINAL OPERATION 9 0.0007
599 DYSPNOEA 412 0.0007
600 TOOTH EXTRACTION 9 0.0007
601 PHARYNGEAL SWELLING 7 0.0007
602 NASAL CONGESTION 42 0.0007
603 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
604 APPLICATION SITE REACTION 5 0.0007
605 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
606 CARDIOVASCULAR DISORDER 18 0.0007
607 HEART RATE IRREGULAR 16 0.0007
608 THERAPY PARTIAL RESPONDER 11 0.0007
609 ASTHENIA 265 0.0007
610 ROTATOR CUFF SYNDROME 9 0.0007
611 EYE DISORDER 23 0.0007
612 NEURALGIA 17 0.0007
613 INFUSION SITE PAIN 9 0.0007
614 CARDIAC FAILURE 56 0.0007
615 EMPHYSEMA 7 0.0007
616 DEPRESSION 156 0.0007
617 SARS-COV-2 TEST POSITIVE 9 0.0007
618 POST PROCEDURAL COMPLICATION 13 0.0007
619 SKIN HAEMORRHAGE 10 0.0007
620 MALAISE 295 0.0007
621 CHOLECYSTITIS 8 0.0007
622 PULMONARY MASS 10 0.0007
623 PNEUMONIA 216 0.0007
624 PALLOR 18 0.0007
625 JOINT INJURY 14 0.0007
626 RESPIRATORY DEPRESSION 8 0.0007
627 HYPOACUSIS 28 0.0006
628 GRAND MAL CONVULSION 6 0.0006
629 FLUID RETENTION 33 0.0006
630 SURGERY 38 0.0006
631 ANKLE FRACTURE 10 0.0006
632 ACUTE MYOCARDIAL INFARCTION 19 0.0006
633 APNOEA 5 0.0006
634 INTENTIONAL PRODUCT MISUSE 56 0.0006
635 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
636 SQUAMOUS CELL CARCINOMA 6 0.0006
637 CONTUSION 61 0.0006
638 ARRHYTHMIA 30 0.0006
639 CRYING 23 0.0006
640 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
641 DECREASED APPETITE 146 0.0006
642 CYSTITIS 20 0.0006
643 DRUG WITHDRAWAL SYNDROME 55 0.0006
644 SUICIDE ATTEMPT 38 0.0006
645 ORAL PAIN 14 0.0006
646 CATARACT 37 0.0006
647 RESPIRATORY FAILURE 45 0.0006
648 CHOLECYSTECTOMY 7 0.0006
649 INTERNAL HAEMORRHAGE 7 0.0006
650 THERAPY CHANGE 6 0.0006
651 PERIPHERAL SWELLING 94 0.0006
652 SEPSIS 68 0.0006
653 BLOOD PRESSURE INCREASED 93 0.0006
654 GASTRITIS 16 0.0006
655 LEUKOCYTOSIS 11 0.0006
656 MUSCLE TWITCHING 14 0.0006
657 ABASIA 15 0.0006
658 FATIGUE 472 0.0006
659 PRODUCT DOSE OMISSION ISSUE 178 0.0006
660 DRUG LEVEL INCREASED 10 0.0006
661 ELECTROLYTE IMBALANCE 7 0.0006
662 ILLNESS 62 0.0006
663 SPLENOMEGALY 7 0.0006
664 BLOOD UREA INCREASED 10 0.0006
665 PRODUCT DISPENSING ERROR 13 0.0006
666 CHEST DISCOMFORT 61 0.0006
667 CARDIAC ARREST 49 0.0006
668 IMPAIRED GASTRIC EMPTYING 8 0.0006
669 CEREBRAL HAEMORRHAGE 21 0.0006
670 AKATHISIA 8 0.0006
671 OEDEMA PERIPHERAL 71 0.0006
672 MUSCULOSKELETAL DISCOMFORT 10 0.0006
673 PULMONARY OEDEMA 26 0.0006
674 FOOT FRACTURE 11 0.0006
675 RESPIRATORY TRACT INFECTION 15 0.0006
676 CEREBRAL INFARCTION 14 0.0006
677 KNEE ARTHROPLASTY 12 0.0006
678 AMNESIA 37 0.0006
679 BLOOD POTASSIUM DECREASED 17 0.0006
680 SEASONAL ALLERGY 8 0.0006
681 SCIATICA 9 0.0006
682 PHARYNGITIS 7 0.0006
683 COVID-19 99 0.0006
684 BODY HEIGHT DECREASED 6 0.0006
685 DRUG EFFECT DECREASED 30 0.0006
686 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
687 BLOOD PRESSURE ABNORMAL 11 0.0006
688 HYPERTHYROIDISM 8 0.0006
689 MUSCLE ATROPHY 7 0.0006
690 C-REACTIVE PROTEIN INCREASED 20 0.0005
691 OESOPHAGITIS 6 0.0005
692 VISUAL IMPAIRMENT 68 0.0005
693 GASTROENTERITIS 8 0.0005
694 BACK PAIN 127 0.0005
695 INTENTIONAL OVERDOSE 35 0.0005
696 TOXICITY TO VARIOUS AGENTS 92 0.0005
697 NAUSEA 430 0.0005
698 EXTRA DOSE ADMINISTERED 22 0.0005
699 BURNING SENSATION 38 0.0005
700 VENTRICULAR FIBRILLATION 6 0.0005
701 APPENDICITIS 5 0.0005
702 NEPHROPATHY TOXIC 6 0.0005
703 BLOOD CALCIUM DECREASED 6 0.0005
704 TARDIVE DYSKINESIA 15 0.0005
705 ORAL CANDIDIASIS 7 0.0005
706 STATUS EPILEPTICUS 6 0.0005
707 ARTERIOSCLEROSIS 5 0.0005
708 SUICIDAL IDEATION 48 0.0005
709 NEPHROLITHIASIS 24 0.0005
710 PRODUCT USE ISSUE 98 0.0005
711 FREQUENT BOWEL MOVEMENTS 14 0.0005
712 ABDOMINAL DISTENSION 54 0.0005
713 PULMONARY EMBOLISM 49 0.0005
714 LIMB INJURY 14 0.0005
715 EJECTION FRACTION DECREASED 8 0.0005
716 HYPOXIA 18 0.0005
717 HAEMATOCRIT DECREASED 10 0.0005
718 MEDICATION ERROR 28 0.0005
719 THIRST 9 0.0005
720 ANGER 17 0.0005
721 ACCIDENT 6 0.0005
722 ROAD TRAFFIC ACCIDENT 21 0.0005
723 MOOD SWINGS 16 0.0005
724 BRAIN INJURY 5 0.0005
725 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
726 ACUTE KIDNEY INJURY 76 0.0005
727 STEVENS-JOHNSON SYNDROME 11 0.0005
728 ATRIAL FIBRILLATION 48 0.0005
729 DRUG ABUSE 41 0.0005
730 BODY TEMPERATURE INCREASED 10 0.0005
731 MUSCLE SPASTICITY 6 0.0005
732 TENDON RUPTURE 6 0.0005
733 HYPERCALCAEMIA 6 0.0005
734 DEVICE LEAKAGE 21 0.0005
735 PERITONITIS 10 0.0005
736 SEPTIC SHOCK 21 0.0005
737 VOMITING 225 0.0005
738 ECZEMA 25 0.0005
739 HYPOKALAEMIA 22 0.0005
740 RENAL FAILURE 63 0.0005
741 BRONCHITIS 35 0.0005
742 HYPERTENSION 100 0.0005
743 DEVICE MALFUNCTION 33 0.0005
744 PAIN IN EXTREMITY 138 0.0005
745 RESPIRATORY DISORDER 14 0.0005
746 NECK PAIN 26 0.0005
747 DEVICE USE ERROR 16 0.0005
748 PLEURAL EFFUSION 28 0.0005
749 DEVICE FAILURE 7 0.0005
750 NODULE 6 0.0005
751 BLOOD CREATININE INCREASED 30 0.0005
752 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
753 JOINT STIFFNESS 12 0.0005
754 HIP ARTHROPLASTY 7 0.0005
755 FEELING HOT 28 0.0005
756 DEVICE ADHESION ISSUE 7 0.0005
757 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
758 LYMPHOCYTE COUNT DECREASED 8 0.0005
759 ADVERSE REACTION 6 0.0005
760 TACHYCARDIA 40 0.0004
761 INTENTIONAL SELF-INJURY 9 0.0004
762 CHEST PAIN 82 0.0004
763 APPLICATION SITE PRURITUS 10 0.0004
764 HYPOTHYROIDISM 14 0.0004
765 RESPIRATORY DISTRESS 12 0.0004
766 DYSURIA 16 0.0004
767 MASS 6 0.0004
768 THERAPEUTIC RESPONSE DECREASED 26 0.0004
769 HYPERKALAEMIA 15 0.0004
770 HYPOAESTHESIA 64 0.0004
771 HAEMATOMA 11 0.0004
772 VENTRICULAR TACHYCARDIA 7 0.0004
773 FLATULENCE 24 0.0004
774 VIRAL INFECTION 14 0.0004
775 DEAFNESS 11 0.0004
776 MUSCULOSKELETAL DISORDER 8 0.0004
777 APPLICATION SITE ERYTHEMA 11 0.0004
778 MYALGIA 71 0.0004
779 ABDOMINAL PAIN 97 0.0004
780 ACCIDENTAL UNDERDOSE 6 0.0004
781 PANCREATITIS 22 0.0004
782 PRODUCT STORAGE ERROR 36 0.0004
783 ACCIDENTAL OVERDOSE 15 0.0004
784 CARDIO-RESPIRATORY ARREST 17 0.0004
785 METABOLIC ACIDOSIS 13 0.0004
786 CARDIOMYOPATHY 6 0.0004
787 SINUS DISORDER 8 0.0004
788 COLON CANCER 6 0.0004
789 AGEUSIA 10 0.0004
790 RESPIRATORY ARREST 11 0.0004
791 SEIZURE 46 0.0004
792 CEREBROVASCULAR ACCIDENT 67 0.0004
793 RENAL IMPAIRMENT 33 0.0004
794 PRODUCT ADHESION ISSUE 14 0.0004
795 FUNGAL INFECTION 13 0.0004
796 DRUG RESISTANCE 10 0.0004
797 OSTEOPOROSIS 16 0.0004
798 INFLAMMATION 20 0.0004
799 TOOTHACHE 7 0.0004
800 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
801 PULMONARY HYPERTENSION 8 0.0004
802 WEIGHT INCREASED 86 0.0004
803 INFECTION 55 0.0004
804 AGRANULOCYTOSIS 7 0.0004
805 ABSCESS 6 0.0004
806 PAIN 231 0.0004
807 ABDOMINAL DISCOMFORT 63 0.0004
808 CARDIAC DISORDER 35 0.0004
809 LOCALISED INFECTION 9 0.0004
810 INTESTINAL OBSTRUCTION 14 0.0004
811 OVERDOSE 80 0.0004
812 OFF LABEL USE 323 0.0004
813 ANAEMIA 70 0.0004
814 DYSPEPSIA 36 0.0004
815 IMPAIRED HEALING 12 0.0004
816 LETHARGY 21 0.0004
817 PULMONARY FIBROSIS 7 0.0004
818 HOSPITALISATION 56 0.0004
819 MELAENA 8 0.0004
820 PHOTOSENSITIVITY REACTION 6 0.0004
821 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
822 ERUCTATION 7 0.0004
823 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
824 HEPATOTOXICITY 8 0.0004
825 HAEMOPTYSIS 10 0.0004
826 GASTROINTESTINAL DISORDER 32 0.0004
827 CARPAL TUNNEL SYNDROME 5 0.0004
828 PARAESTHESIA 56 0.0004
829 OXYGEN SATURATION DECREASED 20 0.0004
830 BLOOD TEST ABNORMAL 5 0.0004
831 HEMIPARESIS 6 0.0004
832 OSTEOARTHRITIS 15 0.0004
833 HEART RATE INCREASED 35 0.0004
834 PAIN IN JAW 10 0.0004
835 NERVOUS SYSTEM DISORDER 11 0.0004
836 INTENTIONAL DOSE OMISSION 10 0.0004
837 BRONCHOSPASM 5 0.0004
838 OEDEMA 19 0.0003
839 RED BLOOD CELL COUNT DECREASED 10 0.0003
840 ANGINA PECTORIS 10 0.0003
841 CARDIOGENIC SHOCK 5 0.0003
842 EPISTAXIS 26 0.0003
843 NASOPHARYNGITIS 64 0.0003
844 VERTIGO 21 0.0003
845 LIVER FUNCTION TEST ABNORMAL 10 0.0003
846 HEADACHE 214 0.0003
847 LACTIC ACIDOSIS 11 0.0003
848 ISCHAEMIC STROKE 6 0.0003
849 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
850 STAPHYLOCOCCAL INFECTION 11 0.0003
851 MOUTH ULCERATION 7 0.0003
852 BONE DISORDER 6 0.0003
853 SKIN LESION 9 0.0003
854 TYPE 2 DIABETES MELLITUS 11 0.0003
855 SKIN DISCOLOURATION 15 0.0003
856 LIVER FUNCTION TEST INCREASED 7 0.0003
857 SKIN CANCER 7 0.0003
858 THROMBOSIS 26 0.0003
859 FAECES DISCOLOURED 7 0.0003
860 HEPATIC STEATOSIS 6 0.0003
861 THROMBOCYTOPENIA 36 0.0003
862 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
863 BLOOD URINE PRESENT 6 0.0003
864 PALPITATIONS 37 0.0003
865 HAEMORRHAGE 33 0.0003
866 TRANSAMINASES INCREASED 7 0.0003
867 INCREASED APPETITE 6 0.0003
868 NIGHT SWEATS 10 0.0003
869 SKIN ULCER 8 0.0003
870 PYREXIA 107 0.0003
871 RENAL FAILURE ACUTE 13 0.0003
872 RENAL DISORDER 14 0.0003
873 SKIN DISORDER 10 0.0003
874 INJURY 21 0.0003
875 NEUTROPHIL COUNT DECREASED 12 0.0003
876 VISION BLURRED 40 0.0003
877 PRODUCT DOSE OMISSION 19 0.0003
878 PRODUCT USE IN UNAPPROVED INDICATION 72 0.0003
879 HAEMATOCHEZIA 16 0.0003
880 ARTHRALGIA 119 0.0003
881 TINNITUS 13 0.0003
882 LEUKOPENIA 14 0.0003
883 INFLUENZA 31 0.0003
884 ABDOMINAL PAIN UPPER 57 0.0003
885 ABDOMINAL PAIN LOWER 7 0.0003
886 HYPOGLYCAEMIA 13 0.0003
887 ARTHRITIS 21 0.0003
888 PANCREATITIS ACUTE 6 0.0003
889 ANHEDONIA 7 0.0003
890 TREATMENT FAILURE 22 0.0003
891 JOINT SWELLING 32 0.0003
892 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
893 COLITIS 10 0.0003
894 HAEMOGLOBIN DECREASED 27 0.0003
895 NEUROPATHY PERIPHERAL 25 0.0003
896 DRUG ADMINISTRATION ERROR 8 0.0003
897 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
898 JAUNDICE 7 0.0003
899 RASH PRURITIC 14 0.0003
900 CELLULITIS 13 0.0003
901 RASH MACULAR 9 0.0003
902 ASTHMA 29 0.0003
903 SWELLING 24 0.0003
904 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
905 CHRONIC KIDNEY DISEASE 19 0.0002
906 DIABETES MELLITUS 19 0.0002
907 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
908 MUSCULOSKELETAL PAIN 13 0.0002
909 ERYTHEMA 51 0.0002
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
911 MYOCARDIAL INFARCTION 42 0.0002
912 SKIN IRRITATION 11 0.0002
913 DYSPNOEA EXERTIONAL 9 0.0002
914 GASTRIC CANCER 6 0.0002
915 CARDIAC FAILURE CONGESTIVE 19 0.0002
916 ERECTILE DYSFUNCTION 6 0.0002
917 SWELLING FACE 15 0.0002
918 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
919 HERPES ZOSTER 13 0.0002
920 HOT FLUSH 17 0.0002
921 CHILLS 26 0.0002
922 DRY EYE 11 0.0002
923 DIARRHOEA 141 0.0002
924 STOMATITIS 13 0.0002
925 BLISTER 12 0.0002
926 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
927 VISUAL ACUITY REDUCED 7 0.0002
928 DISEASE RECURRENCE 10 0.0002
929 LIP SWELLING 7 0.0002
930 HYPERSENSITIVITY 39 0.0002
931 NEOPLASM MALIGNANT 14 0.0002
932 EYE IRRITATION 12 0.0002
933 BLOOD GLUCOSE DECREASED 10 0.0002
934 BONE PAIN 12 0.0002
935 HAEMATURIA 7 0.0002
936 GASTRIC DISORDER 7 0.0002
937 LABORATORY TEST ABNORMAL 6 0.0002
938 LIVER DISORDER 9 0.0002
939 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
940 HEPATIC FAILURE 6 0.0002
941 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
942 DRUG EFFECT INCOMPLETE 7 0.0002
943 BLOOD BILIRUBIN INCREASED 5 0.0002
944 CHOLELITHIASIS 6 0.0002
945 ARTHROPATHY 10 0.0002
946 EYE PRURITUS 6 0.0002
947 CONVULSION 10 0.0002
948 DRUG DEPENDENCE 28 0.0002
949 BLADDER CANCER 10 0.0002
950 LYMPHADENOPATHY 6 0.0002
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
952 RASH ERYTHEMATOUS 8 0.0002
953 INTERSTITIAL LUNG DISEASE 8 0.0002
954 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
955 RECTAL HAEMORRHAGE 7 0.0002
956 HEPATIC FUNCTION ABNORMAL 6 0.0002
957 COMPLETED SUICIDE 13 0.0002
958 BLOOD GLUCOSE INCREASED 29 0.0002
959 RASH 67 0.0002
960 ALOPECIA 30 0.0002
961 EMOTIONAL DISTRESS 18 0.0001
962 LUNG NEOPLASM MALIGNANT 6 0.0001
963 PRODUCT QUALITY ISSUE 19 0.0001
964 DEEP VEIN THROMBOSIS 9 0.0001
965 INJECTION SITE BRUISING 11 0.0001
966 SINUSITIS 14 0.0001
967 COLITIS ULCERATIVE 6 0.0001
968 RHEUMATOID ARTHRITIS 15 0.0001
969 PRURITUS 50 0.0001
970 DRUG DOSE OMISSION BY DEVICE 10 0.0001
971 OCULAR HYPERAEMIA 6 0.0001
972 DRY SKIN 16 0.0001
973 INJECTION SITE PRURITUS 8 0.0001
974 HEPATIC ENZYME INCREASED 8 0.0001
975 DEPENDENCE 6 0.0001
976 INFLUENZA LIKE ILLNESS 9 0.0001
977 NO ADVERSE EVENT 19 0.0001
978 INJECTION SITE SWELLING 8 0.0001
979 DRUG DOSE OMISSION 17 0.0001
980 FLUSHING 10 0.0001
981 NEUTROPENIA 13 0.0001
982 URTICARIA 16 0.0001
983 INJECTION SITE ERYTHEMA 11 0.0001
984 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
985 MIGRAINE 8 0.0001
986 PROSTATE CANCER 6 0.0001
987 SKIN EXFOLIATION 6 0.0001
988 ACNE 5 0.0001
989 BREAST CANCER 6 0.0001
990 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
991 PLATELET COUNT DECREASED 6 0.0001
992 PSORIASIS 6 0.0000
993 INJECTION SITE PAIN 12 0.0000